These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers. Addanki S; Meas S; Sarli VN; Singh B; Lucci A Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887191 [TBL] [Abstract][Full Text] [Related]
63. The potential of liquid biopsies in gastrointestinal cancer. Wu C; Zhang J; Li H; Xu W; Zhang X Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214 [TBL] [Abstract][Full Text] [Related]
64. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer. Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353 [TBL] [Abstract][Full Text] [Related]
65. Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care. Aquino IMC; Pascut D Ann Hepatol; 2024; 29(2):101176. PubMed ID: 37972709 [TBL] [Abstract][Full Text] [Related]
66. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer. Raza A; Khan AQ; Inchakalody VP; Mestiri S; Yoosuf ZSKM; Bedhiafi T; El-Ella DMA; Taib N; Hydrose S; Akbar S; Fernandes Q; Al-Zaidan L; Krishnankutty R; Merhi M; Uddin S; Dermime S J Exp Clin Cancer Res; 2022 Mar; 41(1):99. PubMed ID: 35292091 [TBL] [Abstract][Full Text] [Related]
67. Monitoring of cancer patients via next-generation sequencing of patient-derived circulating tumor cells and tumor DNA. Onidani K; Shoji H; Kakizaki T; Yoshimoto S; Okaya S; Miura N; Sekikawa S; Furuta K; Lim CT; Shibahara T; Boku N; Kato K; Honda K Cancer Sci; 2019 Aug; 110(8):2590-2599. PubMed ID: 31169336 [TBL] [Abstract][Full Text] [Related]
68. [The prospect and challenge of liquid biopsy in the diagnosis and treatment of chest malignancy]. Ma LF; Zeng BJ; Wang XZ; Zhang X; Wang JY Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jul; 57(7):968-975. PubMed ID: 37482733 [TBL] [Abstract][Full Text] [Related]
69. An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer. Mollica V; Di Nunno V; Santoni M; Cimadamore A; Scarpelli M; Lopez-Beltran A; Cheng L; Mariani C; Battelli N; Montironi R; Massari F Expert Rev Mol Diagn; 2020 Feb; 20(2):207-217. PubMed ID: 31640441 [No Abstract] [Full Text] [Related]
70. Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer. Freitas AJA; Causin RL; Varuzza MB; Calfa S; Hidalgo Filho CMT; Komoto TT; Souza CP; Marques MMC Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077348 [TBL] [Abstract][Full Text] [Related]
72. Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy. Marrugo-Ramírez J; Mir M; Samitier J Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248975 [TBL] [Abstract][Full Text] [Related]
74. [Current Status and Prospects of Liquid Biopsy for Hepatocellular Carcinoma]. Kang J; Kim SS Korean J Gastroenterol; 2023 Jul; 82(1):1-9. PubMed ID: 37489076 [TBL] [Abstract][Full Text] [Related]
75. Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications. Shah UJ; Alsulimani A; Ahmad F; Mathkor DM; Alsaieedi A; Harakeh S; Nasiruddin M; Haque S Biotechnol Genet Eng Rev; 2022 Oct; 38(2):339-383. PubMed ID: 35968863 [TBL] [Abstract][Full Text] [Related]
76. Circulating Tumor Cell-Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue-Based Messenger RNA Profiling Into a Noninvasive Setting. Lee YT; Sun N; Kim M; Wang JJ; Tran BV; Zhang RY; Qi D; Zhang C; Chen PJ; Sadeghi S; Finn RS; Saab S; Han SB; Busuttil RW; Pei R; Zhu Y; Tseng HR; You S; Yang JD; Agopian VG Liver Transpl; 2022 Feb; 28(2):200-214. PubMed ID: 34664394 [TBL] [Abstract][Full Text] [Related]